Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy
Open Access
- 13 September 2004
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (4) , 331-337
- https://doi.org/10.1111/j.1365-2796.2004.01367.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurementJournal Of Hypertension, 2003
- Vascular Endothelial Growth Factor Enhances Cardiac Allograft ArteriosclerosisCirculation, 2002
- Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and β-Thromboglobulin Levels in Atrial FibrillationStroke, 2002
- Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and plateletsScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Vascular endothelial growth factor: angiogenesis, atherogenesis or both?Journal of the American College of Cardiology, 2001
- Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure.Journal of Clinical Investigation, 1997
- Hypothesis: is soluble P-selectin a new marker of platelet activation?Atherosclerosis, 1997
- The Role of Platelets in Essential HypertensionBlood Pressure, 1995
- Receptor-activated Ca2+ influx: how many mechanisms for how many channels?Trends in Pharmacological Sciences, 1994
- Calcium Signaling In Human PlateletsAnnual Review of Physiology, 1990